These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report. Kuroda T, Takeuchi H, Nozawa Y, Sato H, Nakatsue T, Wada Y, Moriyama H, Nakano M, Narita I. BMC Res Notes; 2016 Apr 26; 9():240. PubMed ID: 27113212 [Abstract] [Full Text] [Related]
5. Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody. Mori S, Imamura F, Kiyofuji C, Ito K, Koga Y, Honda I, Sugimoto M. Mod Rheumatol; 2006 Apr 26; 16(1):58-62. PubMed ID: 16622728 [Abstract] [Full Text] [Related]
6. Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with Pneumocystis jirovecii pneumonia. Gochi M, Takayanagi N, Ishiguro T, Miyahara Y, Yanagisawa T, Shimizu Y, Sugita Y. Intern Med; 2014 Apr 26; 53(11):1137-41. PubMed ID: 24881737 [Abstract] [Full Text] [Related]
7. Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum. Shimada K, Yokosuka K, Nunokawa T, Sugii S. Clin Rheumatol; 2018 Aug 26; 37(8):2269-2274. PubMed ID: 29876690 [Abstract] [Full Text] [Related]
8. Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia. Matsumura Y, Ito Y, Yamamoto M, Matsushima A, Nagao M, Takakura S, Iinuma Y, Ichiyama S. J Infect Chemother; 2014 Feb 26; 20(2):109-14. PubMed ID: 24480550 [Abstract] [Full Text] [Related]
12. [A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia]. Shimada T, Nishimura Y, Funada Y, Takenaka K, Kobayashi K, Urata Y, Yosimura S, Nishiuma T, Satouchi M, Yokoyama M. Arerugi; 2004 Jun 26; 53(6):575-81. PubMed ID: 15247519 [Abstract] [Full Text] [Related]
14. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study. Tokuda H, Sakai F, Yamada H, Johkoh T, Imamura A, Dohi M, Hirakata M, Yamada T, Kamatani N, Kikuchi Y, Sugii S, Takeuchi T, Tateda K, Goto H. Intern Med; 2008 Jun 26; 47(10):915-23. PubMed ID: 18480575 [Abstract] [Full Text] [Related]
15. Usefulness of beta-D glucan in diagnosing Pneumocystis carinii pneumonia and monitoring its treatment in a living-donor liver-transplant recipient. Kawagishi N, Miyagi S, Satoh K, Akamatsu Y, Sekiguchi S, Satomi S. J Hepatobiliary Pancreat Surg; 2007 Jun 26; 14(3):308-11. PubMed ID: 17520208 [Abstract] [Full Text] [Related]
16. Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab. Kalyoncu U, Karadag O, Akdogan A, Kisacik B, Erman M, Erguven S, Ertenli AI. Scand J Infect Dis; 2007 Jun 26; 39(5):475-8. PubMed ID: 17464877 [Abstract] [Full Text] [Related]
17. Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an Intensive Care Unit: a case report. Saito T, Shime N, Itoh K, Fujita N, Saito Y, Shinozaki M, Shibuya K, Makimura K, Hashimoto S. Infection; 2009 Dec 26; 37(6):547-50. PubMed ID: 19730788 [Abstract] [Full Text] [Related]